April 25, 2025 02:33 PM EDT

Amgen invests $900M to expand Ohio biomanufacturing

Zachary Brennan

Senior Editor

Amgen is the latest in a series of biopharma companies to announce a massive new US-based investment in manufacturing in response to the Trump administration’ …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Amgen invests $900M to expand Ohio biomanufacturing

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

New fund will pressure flailing biotechs, as investor frustration boils over

Akeso shares new data suggesting it can beat Keytruda on survival, wins China approval

FDA chief Makary talks expediting drug approvals, RIFs and the abortion pill

AbbVie commits $10B to expand US footprint with the threat of tariffs ahead

Merck KGaA closes in on SpringWorks deal at $3.5B price point

ADSTILADRIN® (nadofaragene firadenovec-vncg) – A Growing Body of Clinical Data and Real-World Evidence

Am­gen in­vests $900M to ex­pand Ohio bio­man­u­fac­tur­ing

Senior Editor

Sign up to read this article for free.

Celldex Therapeutics

Hampton, NJ, USA

Amgen invests $900M to expand Ohio biomanufacturing